News
Jun 14, 2022
AlveoliX winner of the Swiss Medtech Award 2022
🏆 We made it! We are the winner of the Swiss Medtech Award 2022 🙏 A big thank you to the AlveoliX team for their commitment and to all the people who support us.– ARTORG Center for Biomedical Engineering Research– Insel Gruppe– Innosuisse– Bern Economic Development Agency 👏🏼 Thank you to the jury for choosing...
May 25, 2022
Close collaboration with CSL and Insel Gruppe
🌐 CSL Behring, Insel Gruppe and AlveoliX have joined forces within sitem-insel AG’s hub to improve translation and find new treatments for lung diseases. 🔬 Discover how this close collaboration works for the benefit of patients. 📰 Learn more about this cooperation success story in this article by Jasmin Joller (available in EN, DE, FR)....
May 10, 2022
New partnership with InSCREENeX
🔥 We are very excited to announce our partnership with InSCREENeX GmbH. 🤝 By joining forces and combining InSCREENeX’ cutting-edge CI-SCREEN methodology with AlveoliX’ patented organ-on-chip technology, we co-developed a new immortalized alveolar cell line, specially tuned for on-chip applications. 🧫 AXiAECs derived from primary alveolar epithelial cells and grown on-chip feature key aspects of...
Mar 25, 2022
AlveoliX shortlisted for the Swiss Medtech Award 2022
AlveoliX has been shortlisted for the Swiss Medtech Award 2022! We will be pitching our company to the Jury on April 6th. Looking forward to the hearing! Thank you Swiss Medtech for choosing AlveoliX as one of the 6 companies invited to participate in the vibrant Swiss Medtech Award 2022. More info about the shortlisted candidates HERE.
